» Articles » PMID: 18087172

Evidence for Increased Risk of Prediabetes in the Uremic Patient

Overview
Publisher Karger
Specialty Nephrology
Date 2007 Dec 19
PMID 18087172
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

A prediabetic state is defined as a higher than normal blood glucose level but not yet high enough to meet the diagnosis of overt diabetes mellitus. While patients with advanced diabetic nephropathy are vulnerable to hypoglycemia, we believe that there is sufficient evidence that uremic nondiabetic patients are susceptible to hyperglycemia, which calls for more attention that uremia is a prediabetic state. It is, therefore, intriguing to identify these uremic factors which lead to prediabetes. Such a study may have significance to improve uremic patients' outcomes. To raise the awareness of the uremic prediabetic state, this review will, therefore, elaborate on the analysis of factors important in the development of prediabetes in uremia and will delineate whether their modification leads to an improved patient outcome.

Citing Articles

Cardiometabolic factors and vitamin D deficiency in pediatric patients with chronic kidney disease.

Parra-Ortega I, Zurita-Cruz J, Villasis-Keever M, Klunder-Klunder M, Vilchis-Gil J, Zepeda-Martinez C Front Nutr. 2024; 11:1480424.

PMID: 39439522 PMC: 11493722. DOI: 10.3389/fnut.2024.1480424.


Use of Glucose-Lowering Agents in Diabetes and CKD.

Alicic R, Neumiller J, Galindo R, Tuttle K Kidney Int Rep. 2022; 7(12):2589-2607.

PMID: 36506243 PMC: 9727535. DOI: 10.1016/j.ekir.2022.09.018.


Comprehensive risk profiles of family history and lifestyle and metabolic risk factors in relation to diabetes: A prospective cohort study.

Ye C, Wang Y, Kong L, Zhao Z, Li M, Xu Y J Diabetes. 2022; 14(6):414-424.

PMID: 35762391 PMC: 9366567. DOI: 10.1111/1753-0407.13289.


Cardiac metabolic remodelling in chronic kidney disease.

Patel N, Yaqoob M, Aksentijevic D Nat Rev Nephrol. 2022; 18(8):524-537.

PMID: 35637381 DOI: 10.1038/s41581-022-00576-x.


Plasma Metabolomics Reveals Metabolic Profiling For Diabetic Retinopathy and Disease Progression.

Sun Y, Zou H, Li X, Xu S, Liu C Front Endocrinol (Lausanne). 2021; 12:757088.

PMID: 34777253 PMC: 8589034. DOI: 10.3389/fendo.2021.757088.